Investigation of inhaled Salmeterol/ Fluticasone propionate (SFC) in patient with COPD

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2011
INTERVENTION: Inhaled Salmeterol/ Fluticasone propionate 100 micro gram Inhaled Salmeterol/ Fluticasone propionate 250 micro gram CONDITION: Chronic obstructive pulmonary disease PRIMARY OUTCOME: Changes of FEV1 SECONDARY OUTCOME: QOL, Safety INCLUSION CRITERIA: Patients with chronic obstructive pulmonary disease Patients can use the inhaled thearapy Patients gave written informed consent
Epistemonikos ID: 60a58f6a28f47dcf5d1bc76d8edb5d0a1f41ce5f
First added on: Aug 22, 2024